Changes in insulin like growth factors, myostatin and vascular endothelial growth factor in rat musculus latissimus dorsi by poly-3-hydroxybutyrate implants.

The present study aimed at researching the synergistic effect between an ectopic bone substitute and surrounding muscle tissue. To describe this effect, changes of insulin like growth factors (IGF1, IGF2), myostatin (GDF8) and vascular endothelial growth factor (VEGF) mRNA content of 12 Wistar-King rats musculus latissimus dorsi with implanted poly-3-hydroxybutyrate (PHB) scaffold were examined after 6 and 12 weeks. At each time interval six rats were killed and implants and surrounding tissues prepared for genetic evaluation. Eight rats without any implants served as controls. RNA was extracted from homogenized muscle tissue and reverse transcribed. Changes in mRNA content were measured by Real-Time PCR using specific primers for IGF1, IGF2, GDF8 and VEGF. Comparing the level of VEGF mRNA in muscle after 6 and 12 weeks to the controls, we could assess a significant increase of VEGF gene expression (p<0.05) whereas the level of mRNA expression was higher after 6 than after 12 weeks of treatment. Expression of IGF1 gene was also significantly increased as compared to the controls over the observed period of time (p<0.05). In the case of the IGF2 gene, the expression was significantly elevated after 6 weeks (p<0.05), but not significantly increased after 12 weeks (p>0.05). We observed a significantly decreased GDF8 gene expression (p<0.05) both after retrieval of implants after 6 as well as after 12 weeks. Moreover, mRNA level of GDF8 after 6 and 12 weeks were comparable the same. Our results show that PHB implants in rat musculus latissimus dorsi interact with the surrounding muscle tissue. This interaction works itself on growth potential of the muscle.

[1]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[2]  E. Wilson,et al.  Autocrine Growth Factor Signaling by Insulin-like Growth Factor-II Mediates MyoD-stimulated Myocyte Maturation* , 2003, Journal of Biological Chemistry.

[3]  F. Gros,et al.  Autonomous differentiation in the mouse myogenic cell line, C2, involves a mutual positive control between insulin-like growth factor II and MyoD, operating as early as at the myoblast stage. , 1996, Journal of cell science.

[4]  J. Tidball,et al.  Modulation of myostatin expression during modified muscle use , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[5]  Seppo Ylä-Herttuala,et al.  Clinical applications of vascular gene therapy , 2001, Current cardiology reports.

[6]  T. Gedrange,et al.  Intrauterine growth restriction induces increased capillary density and accelerated type I fiber maturation in newborn pig skeletal muscles , 2006, Journal of perinatal medicine.

[7]  Seumas McCroskery,et al.  Myostatin negatively regulates satellite cell activation and self-renewal , 2003, The Journal of cell biology.

[8]  G. Tregear,et al.  Histochemical localization of IGF-I and -II mRNA in the developing rat embryo. , 1987, Development.

[9]  F. Mack,et al.  Adaptation of myosin heavy chain mRNA expression after implantation of poly(3)hydroxybutyrate scaffolds in rat m. latissimus dorsi. , 2008, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.

[10]  H. Brünig,et al.  Melt spinning of poly(3-hydroxybutyrate) fibers for tissue engineering using alpha-cyclodextrin/polymer inclusion complexes as the nucleation agent. , 2006, Macromolecular bioscience.

[11]  M. Hamilton,et al.  Association of insulin-like growth factor mRNA expressions with muscle regeneration in young, adult, and old rats. , 1997, The American journal of physiology.

[12]  J. Baker,et al.  Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r) , 1993, Cell.

[13]  D. Gerrard,et al.  Myostatin expression in porcine tissues: tissue specificity and developmental and postnatal regulation. , 1998, The American journal of physiology.

[14]  J. Hubbell,et al.  The role of actively released fibrin-conjugated VEGF for VEGF receptor 2 gene activation and the enhancement of angiogenesis. , 2008, Biomaterials.

[15]  M. Gelinsky,et al.  O-phospho-l-serine: a modulator of bone healing in calcium-phosphate cements , 2008, Biomedizinische Technik. Biomedical engineering.

[16]  P. Caroni,et al.  Role of muscle insulin-like growth factors in nerve sprouting: suppression of terminal sprouting in paralyzed muscle by IGF-binding protein 4 , 1994, The Journal of cell biology.

[17]  J. Alemán,et al.  Author's address: , 1988 .

[18]  W. Kapelański,et al.  Investigation of polymorphisms in the porcine myostatin (GDF8; MSTN) gene , 2003 .

[19]  R. Crystal,et al.  Focal angiogen therapy using intramyocardial delivery of an adenovirus vector coding for vascular endothelial growth factor 121. , 2000, The Annals of thoracic surgery.

[20]  T. Gedrange,et al.  Long term evaluation of biomaterial application in surgical treatment of periodontitis , 2008 .

[21]  T. Skalak,et al.  Spatial and temporal control of angiogenesis and arterialization using focal applications of VEGF164 and Ang-1. , 2004, American journal of physiology. Heart and circulatory physiology.

[22]  L. Mcleay,et al.  Improved muscle healing through enhanced regeneration and reduced fibrosis in myostatin-null mice , 2005, Journal of Cell Science.

[23]  M. Gelinsky,et al.  Ectopic bone formation in nude rats using human osteoblasts seeded poly(3)hydroxybutyrate embroidery and hydroxyapatite-collagen tapes constructs. , 2006, Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery.

[24]  W. Parkhouse,et al.  The potential role of insulin-like growth factors in skeletal muscle regeneration. , 1996, Canadian journal of applied physiology = Revue canadienne de physiologie appliquee.

[25]  A. Lassar,et al.  Wiring diagrams: regulatory circuits and the control of skeletal myogenesis. , 1994, Current opinion in cell biology.

[26]  G. Kundt,et al.  Different bone sesitivity to malformations induced by procarbazine in fetal rats. , 2008, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.

[27]  F. Mack,et al.  Evaluation of shape and size changes of bone and remodelled bone substitute after different fixation methods. , 2008, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.

[28]  R. Talmadge,et al.  Myosin heavy chain isoform expression following reduced neuromuscular activity: Potential regulatory mechanisms , 2000, Muscle & nerve.

[29]  Aleksander S Popel,et al.  Skeletal muscle VEGF gradients in peripheral arterial disease: simulations of rest and exercise. , 2007, American journal of physiology. Heart and circulatory physiology.

[30]  H. Eufinger,et al.  Growth and transplantation of a custom vascularised bone graft in a man , 2004, The Lancet.

[31]  Michael Kjaer,et al.  Role of extracellular matrix in adaptation of tendon and skeletal muscle to mechanical loading. , 2004, Physiological reviews.

[32]  M. Kasper,et al.  Regional Alterations in Fiber Type Distribution, Capillary Density, and Blood Flow after Lower Jaw Sagittal Advancement in Pig Masticatory Muscles , 2003, Journal of dental research.

[33]  Se-Jin Lee,et al.  Regulation of skeletal muscle mass in mice by a new TGF-p superfamily member , 1997, nature.

[34]  E. Olson,et al.  MEF2: a transcriptional target for signaling pathways controlling skeletal muscle growth and differentiation. , 1999, Current opinion in cell biology.

[35]  T. Volova,et al.  Biocompatibility of polyhydroxybutyrate microspheres: in vitro and in vivo evaluation , 2008, Journal of materials science. Materials in medicine.

[36]  A. Efstratiadis,et al.  A growth-deficiency phenotype in heterozygous mice carrying an insulin-like growth factor II gene disrupted by targeting , 1990, Nature.